Antibacterial activity of nonantibiotics is orthogonal to standard antibiotics

Numerous nonantibiotic drugs have potent antibacterial activity and can adversely affect the human microbiome. The mechanistic underpinning of this toxicity remains largely unknown. We investigated the antibacterial activity of 200 drugs using genetic screens with thousands of barcoded Escherichia coli knockouts. We analyzed 2 million gene-drug interactions underlying drug-specific toxicity. Network-based analysis of drug-drug similarities revealed that antibiotics clustered into modules that are consistent with the mode of action of their established classes, whereas nonantibiotics remained unconnected. Half of the nonantibiotics clustered into separate modules, potentially revealing shared and unexploited targets for new antimicrobials. Analysis of efflux systems revealed that they widely affect antibiotics and nonantibiotics alike, suggesting that the impact of nonantibiotics on antibiotic cross-resistance should be investigated closely in vivo.

Medienart:

E-Artikel

Erscheinungsjahr:

2024

Erschienen:

2024

Enthalten in:

Zur Gesamtaufnahme - volume:384

Enthalten in:

Science (New York, N.Y.) - 384(2024), 6691 vom: 05. Apr., Seite 93-100

Sprache:

Englisch

Beteiligte Personen:

Noto Guillen, Mariana [VerfasserIn]
Li, Carmen [VerfasserIn]
Rosener, Brittany [VerfasserIn]
Mitchell, Amir [VerfasserIn]

Links:

Volltext

Themen:

Anti-Bacterial Agents
Anti-Infective Agents
Journal Article

Anmerkungen:

Date Completed 08.04.2024

Date Revised 17.04.2024

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1126/science.adk7368

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM369737342